CannAssist (OTCQB: CNSC), a unique, enhanced cannabidiol (“CBD”) company, recently announced SEC approval of its Reg. A+ Tier 2 Filing as of Oct. 13, 2020, and an opportunity for investors to purchase shares at a set price stated in filing. “CannAssist International is building digital platforms, implementing a Brand PR and Sales/Marketing Campaign, expanding distribution, building inventory and enhancing the Xceptol brand,” said CannAssist’s CEO and Founder Mark Palumbo. “Gaining approval for the CNSC Reg A offering is an exciting milestone for us as it opens doors for new investors. The capital will help CannAssist’s continued expansion of the brand and help us reach our corporate benchmarks in order to help as many as possible through our unique technology.”
To view the full press release, visit https://ibn.fm/SJkgT
About CannAssist International Corporation
CannAssist produces and sells its cannabidiol (“CBD”) product, “Cibidinol,” which is formulated based on a proprietary process developed by its founder Mark Palumbo. CBD is a non-psychoactive compound found in hemp. CannAssist’s initial research and development work, aimed at enhancing the bioavailability of desired molecular structures, resulted in the creation of a line of CBD products, most notably its CBD product, Cibidinol. Cibidinol will be available in a line of consumable and topical products that the company believes will make enhanced CBD products more available and accessible to consumers. For more information, visit the company’s website at www.CannAssistInternational.com.
NOTE TO INVESTORS: The latest news and updates relating to CNSC are available in the company’s newsroom at https://ibn.fm/CNSC
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.